Cargando…

Surgery is a promising strategy for improving overall survival for stage III-N2 non-small cell lung cancer patients

BACKGROUND: Surgery is commonly used to treat stage I lung cancer patients, whereas radiotherapy is applied to treat stage III lung cancer patients. However, few advanced-stage lung cancer patients benefit from surgery. This study aimed to investigate the efficacy of surgery for stage III-N2 non-sma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jie, Jiang, Chao, Wang, Yue, Qiu, Rong, Su, Jingwei, Liu, Changjiang, Jing, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089857/ https://www.ncbi.nlm.nih.gov/pubmed/37065550 http://dx.doi.org/10.21037/jtd-23-269

Ejemplares similares

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

Adding Erlotinib to Chemoradiation Improves Overall Survival but not Progression-Free Survival in Stage III Non-Small-Cell Lung Cancer
por: Komaki, Ritsuko, et al.
Publicado: (2015)

Neutrophil to lymphocyte ratio can predict overall survival in patients with stage II to III colorectal cancer
por: Cho, Yerim, et al.
Publicado: (2023)

Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer
por: Nie, Ke, et al.
Publicado: (2022)

A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients
por: Oberije, Cary, et al.
Publicado: (2015)

Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database
por: Zhang, Shengchao, et al.
Publicado: (2023)

Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer
por: Bobbili, Priyanka, et al.
Publicado: (2020)

Assessing the Influence of Subsequent Immunotherapy on Overall Survival in Patients with Unresectable Stage III Non–Small Cell Lung Cancer from the PACIFIC Study
por: Ouwens, Mario, et al.
Publicado: (2021)

The Prognostic Nutritional Index before durvalumab after chemoradiation predict the overall survival in patients with stage III non-small cell lung cancer
por: Matsuura, Shun, et al.
Publicado: (2023)

Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer
por: van Uden, Dominique J. P., et al.
Publicado: (2019)

Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC
por: Gray, Jhanelle E., et al.
Publicado: (2019)

A methylomics-associated nomogram predicts the overall survival risk of stage III to IV ovarian cancer
por: Wei, Xuan, et al.
Publicado: (2023)

Ipilimumab, a Promising Immunotherapy with Increased Overall Survival in Metastatic Melanoma?
por: Piérard, Gérald E., et al.
Publicado: (2012)

Impact of therapeutic strategy on disease‐free and overall survival of early‐stage cervical cancer: Surgery alone versus preoperative radiation
por: Mahiou, Katia, et al.
Publicado: (2023)

A nomogram for the prediction of overall survival in patients with stage II and III non-small cell lung cancer using a population-based study
por: Liao, Yi, et al.
Publicado: (2019)

Impact of neutrophil-to-lymphocyte ratio throughout the course of chemoradiotherapy on overall survival and distant failure in unresectable stage III non-small cell lung cancer
por: Kanzaki, Hiromitsu, et al.
Publicado: (2021)

Impacts of post‐radiotherapy lymphocyte count on progression‐free and overall survival in patients with stage III lung cancer
por: Matiello, Juliana, et al.
Publicado: (2020)

Association of a Shortened Duration of Adjuvant Chemotherapy With Overall Survival Among Individuals With Stage III Colon Cancer
por: Boyne, Devon J., et al.
Publicado: (2021)

Postoperative Adjuvant Chemoradiotherapy on the Survival of Stage III Gastric Cancer
por: Li, Chao, et al.
Publicado: (2022)

The Highest Metabolic Activity on FDG PET Is Associated With Overall Survival in Limited-Stage Small-Cell Lung Cancer
por: Kwon, Soo Hyun, et al.
Publicado: (2016)

Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation
por: Chai, Yanfei, et al.
Publicado: (2021)

Postoperative intensity‐modulated radiation therapy reduces local recurrence and improves overall survival in III‐N2 non‐small‐cell lung cancer: A single‐center, retrospective study
por: Wei, Wei, et al.
Publicado: (2020)

Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer
por: Aft, R L, et al.
Publicado: (2012)

PIK3CA and TP53 mutations predict overall survival of stage II/III colorectal cancer patients
por: Li, A-Jian, et al.
Publicado: (2018)

Overall survival after recurrence in stage I–III colorectal cancer patients in accordance with the recurrence organ site and pattern
por: Sawayama, Hiroshi, et al.
Publicado: (2021)

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial
por: Zhong, Wen-Zhao, et al.
Publicado: (2021)

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
por: Dienstmann, R., et al.
Publicado: (2017)

The effect of smoking, obesity and diabetes on recurrence‐free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy
por: Croese, Alex, et al.
Publicado: (2021)

A Prognostic Microenvironment-Related Immune Signature via ESTIMATE (PROMISE Model) Predicts Overall Survival of Patients With Glioma
por: Qiu, Huaide, et al.
Publicado: (2020)

Identification of Biomarkers Correlated with the TNM Staging and Overall Survival of Patients with Bladder Cancer
por: Li, Sheng, et al.
Publicado: (2017)

Prognostic nomograms for predicting cause-specific survival and overall survival of stage I–III colon cancer patients: a large population-based study
por: Zhou, Zheng, et al.
Publicado: (2019)

Evaluating overall survival and competing risks of survival in patients with early‐stage breast cancer using a comprehensive nomogram
por: Xu, Yan‐Bo, et al.
Publicado: (2020)

A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma
por: Li, Jian-Pei, et al.
Publicado: (2016)

Evaluation of Postoperative Radiotherapy Effect on Survival of Resected Stage III-N2 Non-small Cell Lung Cancer Patients
por: Gao, Fei, et al.
Publicado: (2020)

Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer
por: Wang, Chengdi, et al.
Publicado: (2020)

Presence of bone marrow micro‐metastases in stage I‐III colon cancer patients is associated with worse disease‐free and overall survival
por: Viehl, Carsten T., et al.
Publicado: (2017)

Multidisciplinary team discussion results in survival benefit for patients with stage III non-small-cell lung cancer
por: Hung, Hsiu-Ying, et al.
Publicado: (2020)

Positive impact of the negative lymph node count on the survival rate of stage III colon cancer with pN1 and right-side disease
por: Quan, Qi, et al.
Publicado: (2019)

Survival analysis following resection of AJCC stage III gallbladder carcinoma based on different combinations of T and N stages
por: Hwang, Kyoung-Yeon, et al.
Publicado: (2015)

Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients
por: Li, Shunrong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pvi7t6b6sj1m523ivbqq5eqd12